Additional Effect of High-output Current and/or High-duty Cycle in Vagus Nerve Stimulation for Adolescent/Adult Intractable Epilepsy
- PMID: 37045770
- PMCID: PMC10406457
- DOI: 10.2176/jns-nmc.2022-0280
Additional Effect of High-output Current and/or High-duty Cycle in Vagus Nerve Stimulation for Adolescent/Adult Intractable Epilepsy
Abstract
A vagus nerve stimulation (VNS) device delivers electrical pulses to the vagus nerve at a rhythm defined by the duty cycle. The standard therapeutic range is advocated for an output current of 1.5-2.25 mA and a duty cycle of 10%. As the optimal settings vary from patient to patient, some patients may benefit from additional seizure reduction when stimulated beyond the standard range. A total of 74 patients (15 children aged <12 years and 59 adolescents/adults) who underwent VNS implantation between 2011 and 2020 and who were followed up for at least 2 years were included in this retrospective study. Stimulation parameters exceeding 2.25 mA of output current, 25% of duty cycle, and 0.5625 (2.25 mA × 25%) of current × duty cycle were defined as high stimulation. The proportion achieved an additional seizure reduction of 20%, and the 50% seizure reduction rate at the last follow-up was compared between adolescents/adults and children. Approximately 40% of patients in adolescents/adults treated with high stimulation experienced an additional acute effect, resulting in a 50% or greater reduction in seizures in almost all patients. Moreover, in adolescents/adults, 22.2%-41.9% of the patients were treated with high stimulation, and the responder rate was 69.5%. Conversely, the responder rate in children was 26.7%, significantly worse than that in adolescents/adults, despite higher stimulation. VNS with high-stimulation settings is effective for adolescent and adult patients with intractable epilepsy. Even high stimulation may not be effective in extremely refractory pediatric epilepsy with a high seizure frequency.
Keywords: drug-resistant epilepsy; high-duty cycle; high-output current; vagus nerve stimulation.
Conflict of interest statement
All authors have no conflicts of interest directly relevant to the content of this article.
Figures


Similar articles
-
The Efficacy and Safety of Rapid Cycling Vagus Nerve Stimulation in Children With Intractable Epilepsy.Pediatr Neurol. 2020 Aug;109:35-38. doi: 10.1016/j.pediatrneurol.2020.04.003. Epub 2020 Apr 13. Pediatr Neurol. 2020. PMID: 32461031
-
Evaluating vagus nerve stimulation treatment with heart rate monitoring in pediatric patients with intractable epilepsy.Childs Nerv Syst. 2022 Mar;38(3):547-556. doi: 10.1007/s00381-021-05416-0. Epub 2021 Nov 27. Childs Nerv Syst. 2022. PMID: 34837500
-
Use of Vagus Nerve Stimulator on Children With Primary Generalized Epilepsy.J Child Neurol. 2018 Jun;33(7):449-452. doi: 10.1177/0883073818766599. Epub 2018 Apr 13. J Child Neurol. 2018. PMID: 29651891
-
Vagus nerve stimulation (VNS) therapy update.Epilepsy Behav. 2018 Nov;88S:2-10. doi: 10.1016/j.yebeh.2018.06.032. Epub 2018 Jul 13. Epilepsy Behav. 2018. PMID: 30017839 Review.
-
Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.Ont Health Technol Assess Ser. 2013 Oct 1;13(18):1-37. eCollection 2013. Ont Health Technol Assess Ser. 2013. PMID: 24228081 Free PMC article. Review.
Cited by
-
A pilot study on the programming protocol of vagus nerve stimulation in children with drug-resistant epilepsy: High pulse amplitude or high duty cycle.Epilepsia Open. 2025 Jun;10(3):831-841. doi: 10.1002/epi4.70043. Epub 2025 Apr 22. Epilepsia Open. 2025. PMID: 40261679 Free PMC article. Clinical Trial.
-
Epilepsy with Eyelid Myoclonia Complicated by Polycystic Ovary Syndrome: Valproate Withdrawal, Vagus Nerve Stimulation, and Seizure Reduction.NMC Case Rep J. 2023 Nov 11;10:321-325. doi: 10.2176/jns-nmc.2023-0083. eCollection 2023. NMC Case Rep J. 2023. PMID: 38076393 Free PMC article.
References
-
- Wang Y, Zhan G, Cai Z, et al. : Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms. Neurosci Biobehav Rev 127: 37-53, 2021 - PubMed
-
- Toffa DH, Touma L, El Meskine T, Bouthillier A, Nguyen DK: Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: A critical review. Seizure 83: 104-123, 2020 - PubMed
-
- Kawai K, Tanaka T, Baba H, et al. : Outcome of vagus nerve stimulation for drug-resistant epilepsy: The first three years of a prospective Japanese registry. Epileptic Disord 19: 327-338, 2017 - PubMed
-
- Helmers SL, Begnaud J, Cowley A, et al. : Application of a computational model of vagus nerve stimulation. Acta Neurol Scand 126: 336-343, 2012 - PubMed